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Abstract 
Silica iodide catalyzed, competent synthesis of fifteen novel substituted-1,4,5,6-
tetrahydropyridine-3-carboxylate derivatives was achieved by a one-pot four-component 
cyclocondensation of Meldrum’s acid, aryl aldehydes, aromatic amines and ethyl acetoacetate 
under ultrasonic irradiation. In comparison to the conventional methods, our protocol is 
convenient, eco-friendly and offers several benefits such as: mild conditions, high yields, shorter 
reaction time and ease in product isolation.  
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Introduction 
The use of heterogeneous catalysts has received overwhelming attention in recent years as they 
play important role in organic transformations. They have numerous advantages such as ease of 
separation, low cost, high stability, efficient recycling, diminutive metal leaching, improved 
process control, handling and also display characteristic high surface-to-volume ratio in some 
cases. These catalysts can usually be recovered with only small change in activity and selectivity. 
Moreover they exhibit a wider environmental acceptance as they possess benevolent properties 
like low corrosion and insolubility in organic solvents. Silica gel is one of the most widely used 
heterogeneous catalyst which acts as a surface material support for diverse chemical 
transformations.
1
 Among them modified silica gel in the form of silica-chloride (SiO2-Cl), silica-
sulphuric acid (SiO2-OSO3H) and silica iodide (SiO2-I), has shown to behave as an efficient 
catalyst in a wide variety of reactions.
2,3
 
Multicomponent reactions (MCRs) have increasingly induced keen interest amongst the 
scientific community as they provide an elegant and fruitful synthetic route to heterocycles of 
structural complexity and diversity. They have become increasingly prevalent because of their 
green characteristics of efficiency, high facileness and economy in present day synthetic 
chemistry.
4,5
  
The growing interest towards MCRs is because they do not comprise cost and time-consuming 
steps involved in the purification of various precursors and monotonous steps of protection and 
deprotection of functional moieties, which are often cumbersome in traditional linear synthesis.
6
 
By meticulously modifying each block in MCRs and making them react sequentially in an 
intramolecular fashion, the structure of the desired product can be easily designed and can thus 
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result in the generation of combinatorial libraries, divergent synthesis and attractive targets in 
drug discovery.
7,8
 The high chemoselectivity,
9
 regioselectivity
10
 and readily availability of the 
starting materials of the MCRs make the synthesis of heterocycles noteworthy. Heterocycles 
bearing the pyridine scaffold encompass important therapeutic features that make them attractive 
targets for MCRs. They are associated with broad spectrum of biological
11
 and diverse 
pharmacological activities.
12‒16
 Interestingly it was found that, slight structural modifications on 
pyridine ring may cause remarkable changes in the pharmacological properties.
17,18
 In particular, 
tetrahydropyridine molecular frameworks are well renowned for their inherent potential of their 
different biological applications.
19‒21
 A rigorous literature survey revealed, that a few protocols 
have been reported for the synthesis of tetrahydropyridine skeleton
22‒26
 which employs the use of 
Et3N,
27
 ʟ-proline28 and AcOH.29,30 Consequently the survey also shows, that these derivatives 
were not prepared using aryl amines under ultrasonic condition. This synthetic context suggests a 
timely opportunity for devising new approaches to access these relevant scaffolds from readily 
available substrates and by employing mild, inexpensive, green methodologies that are simple, 
economical and ecofriendly. These findings prompted us to combine the known reaction profiles 
in an attempt to achieve an efficient entry into the elusive tetrahydropyridine analogs. 
Additionally, the use of ultrasound has become a very popular convenient synthetic technique as 
it provides smooth access to the target heterocyclic skeleton. Sonication in an organic reaction 
brings about remarkable changes owing to a phenomenon called cavitation, a physical process 
that creates, enlarges and implodes gaseous vapor cavities in a sonicated liquid. As a result, 
extremely elevated pressures and temperatures are reached in the cavities (bubbles) causing the 
stormy in gush of the liquid and thereby intensifying the mass transfer.
31
 Sonochemistry shares 
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similar aims with green chemistry, as it also uses smaller quantities of chemicals and solvents, 
reduces energy consumption and increases product selectivity.
32
 Encouraged by all these facts 
and as a part of our continuing pursuit on the application of ultrasonic irradiation
33,34
 we herein 
report a facile strategy for the synthesis of novel 1,4,5,6-tetrahydropyridine-3-carboxylate 
derivatives by a one-pot four-component reaction of Meldrum’s acid, aryl aldehydes, aromatic 
amines and ethyl acetoacetate in the presence of catalytic silica iodide (SiO2−I) under ultrasonic 
irradiation as shown in Scheme 1. 
Results and discussion 
To explore the feasibility and generality of SiO2–I catalyzed sonicated MCR, the reaction 
conditions including catalyst, solvent and feed ratio of catalyst were optimized to observe their 
role in enhancing the rates and yields of the reaction. Meldrum’s acid (1 mmol), 3,4,5-
trimethoxybenzaldehyde (1 mmol), 4-chloroaniline (1 mmol) and ethyl acetoacetate (1 mmol) 
were chosen as model substrates for these studies. 
Effect of catalyst 
A variety of catalysts were selected in order to authenticate the right choice and the results are 
shown in Table 1. To show the influence of the catalyst, the one-pot four-component reaction 
was first carried out in the absence of catalyst wherein a maximum yield of only 55 % could be 
obtained (Table 1, entry 1). It was further observed, that the yield of the product hardly improved 
in the presence of other general catalysts (Table 1, entries 2−9), whereas the use of SiO2–I as 
catalyst clearly enhanced the yield to 95 % (Table 1, entry 10). Hence, SiO2–I under ultrasonic 
irradiation was selected for our further studies. 
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Effect of solvent 
Various solvents (nonpolar and polar) were screened to substantiate their impact on the rate of 
the reaction and the yield of the product. The results of these studies are presented in Table 2. It 
was found that, compound 5g was not obtained in good yield when solvents were used (Table 2, 
entries 1−9). Later the reaction was performed under solvent-free conditions under sonication 
and it was found, that very good yield (95 %) was obtained under this conditions (Table 2, entry 
10). Hence, further studies were carried out in the absence of a solvent. 
Effect of feed ratio of SiO2–I under sonication 
Next, we examined the amount of catalyst required to promote this positive conversion under the 
influence of ultrasound and the observation of the findings are contained in Table 3. It was noted, 
that variation of the amount of SiO2–I had an effective influence. When 0.1 g of the SiO2–I as 
catalyst was used, the results showed, that maximum yield of the product was obtained (Table 3, 
entry 4). Further, the results also revealed, that excess addition of the catalyst resulted in low 
yields. Accordingly, 0.1 g of SiO2–I under ultrasonic irradiation was found to be the best suitable 
condition for the synthesis of 5g. 
Study on the reusability of SiO2–I under sonication 
To make the process simpler and greener, the recovery and reusability of the catalyst was 
studied. After the completion of the reaction, the solid product obtained was separated and 
ﬁltered along with the catalyst. The residue containing the catalyst was washed with diethyl ether 
to get the solid SiO2–I, which was dried at 100 °C for 1 hour and reused. The results of the study 
of the reusability of the catalyst are presented in the Figure 1. 
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From the above results it is clear, that SiO2–I can be used successively for at least five runs after 
which the yield of the product dropped from 95 % in the ﬁrst fresh run to 80 % in the ﬁfth run. 
The yield of 5g was found to be 95 %, 95 %, 90 %, 85 % and 80 %, respectively, for cycles1–5, 
the marginal decrease of yield in the ﬁrst ﬁve cycles may be due to the loss of the catalyst during 
the recovery. This reusable catalyst is safe, inexpensive, easy to handle, environmentally benign, 
presents fewer disposal problems and is stable in reaction media. 
By employing the optimized reaction conditions, we employed aldehydes and anilines with 
electron withdrawing and electron donating substituents along with ethyl acetoacetate, 
Meldrum’s acid, SiO2–I as catalyst and prepared fifteen novel 1,4,5,6-tetrahydropyridine-3-
carboxylate derivatives 5a-o in excellent yields under sonication. The results of this study are 
presented in the Table 4. 
Mechanistic role of ultrasonic irradiation 
Ultrasonication is an energy efficient technique which is considered to be a green method and is 
used to carry out various transformations. It is also known, that sonication can provide efficient 
stirring.
35 
All these factors can enhance the reaction rates by a million fold times. The present 
reaction is an example of a two-phase system: solid phase (SiO2–I and solid substrates which 
melt initially and give the solid product after the completion of the reaction), and the gas phase 
(dissolved gases in the liquid / liquefied substrates). Ultrasonication near a solid surface causes 
collapse of the bubbles which are non-spherical. This drives high-speed jets of liquid onto the 
surface and creates shockwaves. The impingement of micro-jets and shockwaves in turn 
produces newly exposed highly reactive surfaces on the solid catalysts which are mainly 
responsible for many of the sonochemical effects in solid-liquid heterogeneous reactions. 
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A plausible mechanism for the formation of products 5a-o is illustrated in the Scheme 2. On the 
basis of the chemistry of aldehydes it is reasonable to assume, that the collapse of the cavitation 
bubbles under sonic condition results in high temperature and high pressure and may drive the 
high-speed jets of the aldehyde onto the surface of SiO2–I and enhance its efficiency, and this 
may cause a Knoevenagel condensation of Meldrum’s acid with the SiO2–I activated aldehyde to 
give an intermediate A, which in turn may lose a molecule of water to give ylidene B. Under 
sonic condition ethyl acetoacetate may get activated by the catalyst and condense with aromatic 
aniline to give an intermediate C, which may lose a molecule of water to give enamine D. 
Consequently, the cavitation effect via the energy in-put and material transfer between the 
intermediates B and D may facilitate an in situ Michael-type addition to yield a highly reactive 
intermediate E, which can lose a molecule of acetone, a molecule of CO2 and the catalyst to give 
the desired cyclized product 5 as shown in the Scheme 2. 
Spectroscopic characterization of the products 
The IR spectrum of compound 5h conﬁrmed the presence of aromatic C-H, alkyl CH, ester 
group, aromatic C–C bonds and nitro group due to the appearance of absorption bands at 3015, 
2120, 1740, 1615 and 1550 cm
-1
, respectively. Its 
1
H NMR spectrum indicated the presence of a 
triplet at 1.31 ppm for the –CH2 protons and a quartet at 4.07 ppm for the –CH3 protons. The 
signals at 3.67 and 6.73 ppm confirmed the presence of three methoxy groups of the aromatic 
aldehyde. The area of an NMR signal (the peak intensity), but not the height (the peak 
amplitude), is directly proportional to the number of nuclei contributing to the signal under 
suitable experimental conditions;
36
 hence, the intensity of the methyl peaks are in good 
agreement with the standard data. The disappearance of the singlet at 10.50 ppm of the –CHO 
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group clearly conﬁrmed the cyclization of the Knoevenagel intermediate, multiplets in the range 
7.03–7.68 ppm appeared for the aromatic protons. The 13C NMR of compound 5h showed 
characteristic signals at 35.2, 38.2 and 167.5 ppm indicating the formation of the 
tetrahydropyridine ring and the presence of an ester group. The 
1
H NMR and 
13
C NMR data of 
5h and of the other products are given in the experimental section. The mass spectrum of 5h 
showed a molecular ion peak [M+H] at 471.8 corresponding to the molecular mass. The obtained 
elemental analysis values are in good agreement with the calculated data. The HSQC spectrum 
of the compound 5h showed the exact correlation between the carbon linked to hydrogen and the 
HSQC spectrum matches the individual 
1
H NMR and 
13
C NMR spectra of the compound 5h. 
Conclusions 
We have described a facile, versatile, environmentally benign, rapid and economical protocol for 
the synthesis of novel 1,4,5,6-tetrahydropyridine-3-carboxylate derivatives under ultrasonic 
irradiation. The effect of SiO2–I as a catalyst along with the use of benevolent processes like 
ultrasound is significant for the preparation of 1,4,5,6-tetrahydropyridine-3-carboxylates in 
excellent yield under the aspect of green chemistry. Our ultrasound assisted clean procedure has 
several advantages such as: mild condition, high yields, short reaction durations, ease in product 
isolation and purification compared to the thermally activated conventional methods. Cost 
effective recovery and reusability of the catalyst for a number of times without appreciable loss 
of activity is an additional advantage of the present method. 
To the best of our knowledge, this new procedure provides the ﬁrst example of an efﬁcient and 
ultrasound-promoted approach to the synthesis of 1,4,5,6-tetrahydropyridine-3-carboxylate 
derivatives. 
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Experimental section 
Material and methods 
Reagents and solvents of commercial grade were used without further purification except liquid 
aldehydes and liquid anilines, which were distilled before use. Ultrasonication was performed to 
synthesize all the compounds 5a-o using a commercially available SIDILU, Indian make sonic 
bath working at a constant frequency of 35 kHz and an output power of 70 W at 25 °C 
(maintained by circulating water). The reactions were performed in open vessels without any 
external mechanical stirring. The progress of the reactions and the purity of products were 
assessed by TLC [analytical silica gel plates (Merck60 F254)]. Melting points were determined on 
a RAAGA, Indian make apparatus. The FT-IR (ATR) analysis were carried out on Cary 630 FT-
IR spectrophotometer equipped with diffuse reflectance sampling interface (Agilent 
Technologies, USA). 
1
H NMR and 
13
C NMR spectra were recorded in DMSO-d6 solution with 
an Advance Bruker instrument operating at 400 MHz and 100 MHz, respectively. Chemical 
shifts δ are reported in ppm. ESI-MS analysis was carried out using ESI-Q TOF instrument. 
Elemental analysis was carried out using Vario MICRO CHN analyzer. The Supplemental 
Materials contains sample 1H, 13C NMR and ESI-mass spectra for products 5 (Figures S 1 – S 
46). 
Preparation of SiO2–I 
37
 
Silica gel (20 g) was suspended in CH2Cl2 (50 mL) and SOCl2 (20 mL) was added drop wise 
with continuous stirring at 25 °C. Evolution of HCl and SO2 gases occurred after stirring for 1 h. 
After completion of the reaction the solvent and unreacted SOCl2 was removed by distillation 
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and the residual solvent was removed under reduced pressure to get a dry free flowing solid of 
silica chloride (26.2 g).  
In a clean 50 mL round bottom flask, SiO2–Cl (6 g) was taken and a solution of NaI [prepared by 
dissolving NaI (3 g) in a mixture of EtOH-H2O (8 : 2, 10 mL)] was added to it, stirred well at 25 
°C and ﬁltered after 15 min. The solid thus obtained was then washed with cold water and dried 
under vacuum to get SiO2–I (7.5 g). 
Synthesis of 1,4,5,6-tetrahydropyridine-3-carboxylates 5: General procedure 
A mixture of Meldrum’s acid 1 (1 mmol), aromatic aldehyde 2 (1 mmol), aryl amine 3 (1 mmol), 
ethyl acetoacetate 4 (1 mmol), and SiO2–I (0.1 g) was made in a 50 mL conical flask. The 
mixture was sonicated (35 kHz, constant frequency) at 25 °C (maintained by circulating water 
continuously) for 15 min. After completion of the reaction [monitored by TLC, using n-
hexane:ethyl acetate (8 : 2) as eluent], the reaction mixture was quenched with crushed ice and 
the precipitate formed was filtered, washed, dried and recrystallized from ethanol to get the pure 
product. The structures of all the products were confirmed by IR, 
1
H NMR, 
13
C NMR, ESI-Mass 
spectral and CHN analyses. 
Spectral data 
Ethyl-2-methyl-6-oxo-1,4-diphenyl-1,4,5,6-tetrahydropyridine-3-carboxylate (5a) 
Yellow solid; Yield 87 %; m.p. 140–141 °C. IR (ATR νmax): 3026, 2105, 1750, 1638, 1385, 
1320, 1125 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.36 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.30 (dd, J = 6.8, 4.8 Hz, 1H, −CH22.94 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.82 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.13 (q, J = 6.8 Hz, 2H, −CH2), 7.11−7.58 (m, 10H, Ar-H) 
13
C NMR 
(100 MHz, DMSO-d6): δ 13.3, 15.4, 35.5, 37.4, 60.7, 106.5, 126.3, 126.8, 127.4, 127.8, 128.3, 
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129.4, 137.4, 141.6, 145.7, 165.8, 168.3; ESI-MS calcd. m/z 335.1 found 336.1 [M + H]
+
; Anal. 
Calcd. for C21H21NO3: C, 75.20; H, 6.31; N, 4.18; found: C, 75.22; H, 6.32; N, 4.11 %. 
Ethyl-1-(4'-chlorophenyl)-2-methyl-6-oxo-4-phenyl-1,4,5,6-tetrahydropyridine-3-
carboxylate (5b)  
Yellow solid; Yield 87 %; m.p. 155–156 °C. IR (ATR νmax): 3011, 2115, 1750, 1625, 1353, 1125 
cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.28 (t, J = 6.8 Hz, 3H, −CH3s, 3H, −CH3), 
2.25 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.04 (dd, J = 6.8, 4.8 Hz, 1H, −CH2), 3.90 (dd, J = 6.8, 4.8 
Hz, 1H, −CH), 4.14 (q, J = 6.8 Hz, 2H, −CH2), 7.09−7.64 (m, 9H, Ar-H); 
13
C NMR (100 MHz, 
DMSO-d6): δ 13.2, 16.2, 36.4, 37.9, 61.5, 107.0, 126.2, 126.5, 127.2, 128.3, 128.8, 130.4, 
137.2, 142.5, 146.4, 166.5, 168.6; ESI-MS calcd. m/z 369.1 found 370.1 [M + H]
+
; Anal. Calcd. 
for C21H20ClNO3: C, 68.20; H, 5.45; N, 3.79; found: C, 68.21; H, 5.46; N, 3.81 %. 
Ethyl-4-(4'-chlorophenyl)-2-methyl-6-oxo-1-phenyl-1,4,5,6-tetrahydropyridine-3-
carboxylate (5c)  
Yellow solid; Yield 87 %; m.p. 160–161 °C. IR (ATR νmax): 3030, 2110, 1750, 1620, 1420, 
1335, 1190 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.44 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.28 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.04 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.86 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.20 (q, J = 6.8 Hz, 2H, −CH2), 7.16−7.74 (m, 9H, Ar-H); 
13
C NMR 
(100 MHz, DMSO-d6): δ 13.7, 15.6, 36.5, 37.6, 38.8, 60.8, 106.8, 124.1, 126.2, 127.1, 127.7, 
128.1, 129.8, 136.9, 141.6, 145.3, 165.6, 167.7; ESI-MS calcd. m/z 369.1 found 370.1 [M + H]
+
; 
Anal. Calcd. for C21H20ClNO3: C, 68.20; H, 5.45; N, 3.79. found: C, 68.22; H, 5.47; N, 3.77 %. 
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Ethyl-1,4-bis-(4'-chlorophenyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5d)  
Yellow solid; Yield 90 %; m.p. 176–177 °C. IR (ATR νmax): 3010, 2126, 1740, 1614, 1405, 
1325, 1220 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.40 (t, J = 7.2 Hz, 3H, −CH3s, 
3H, −CH3), 2.29 (dd, J = 7.2, 5.2 Hz, 1H, −CH22.97 (dd, J = 7.2, 5.2 Hz, 1H, −CH23.86 (dd, 
J = 7.2, 5.2 Hz, 1H, −CH), 4.14 (q, J = 7.2 Hz, 2H, −CH2), 7.16−7.63 (m, 8H, Ar-H); 
13
C NMR 
(100 MHz, DMSO-d6): δ 13.2, 16.6, 35.8, 38.1, 60.2, 106.7, 125.5, 127.0, 128.2, 128.5, 129.4, 
137.6, 141.4, 145.8, 165.4, 167.5; ESI-MS calcd. m/z 403.0 found 404.0 [M + H]
+
; Anal. Calcd. 
for C21H19Cl2NO3: C, 62.39; H, 4.74; N, 3.46; O, 11.87. found: C, 62.38; H, 4.77; N, 3.44 %. 
Ethyl-1,4-bis-(4'-bromophenyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5e)  
Yellow solid; Yield 90 %; m.p. 156–157 °C. IR (ATR νmax): 3010, 2105, 1745, 1630, 1428, 
1290, 1214 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.42 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.34 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.03 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.86 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.13 (q, J = 6.8 Hz, 2H, −CH2), 7.05−8.51 (m, 8H, Ar-H); 
13
C NMR 
(100 MHz, DMSO-d6): δ 10.3, 17.5, 32.4, 34.6, 35.4, 56.3, 102.7, 121.7, 122.4, 123.1, 124.4, 
125.1, 133.6, 137.8, 141.6, 161.6, 163.7; ESI-MS calcd. m/z 447.0 found 448.0 [M + H]
+
; Anal. 
Calcd. for C21H19BrClNO3: C, 56.21; H, 4.27; N, 3.12. found: C, 56.78.38; H, 4.32; N, 3.32 %. 
Ethyl-4-(4'-chlorophenyl)-2-methyl-1-(4''-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-
carboxylate (5f)  
Yellow solid; Yield 85 %; m.p. 177–178 °C. IR (ATR νmax): 3051, 2105, 1750, 1596, 1554, 
1332, 1190 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.19 (t, J = 6.8 Hz, 3H, −CH3s, 
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3H, −CH3), 2.24 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.05 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.89 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.14 (q, J = 6.8 Hz, 2H, −CH2), 7.07−7.88 (m, 8H, Ar-H); 
13
C NMR 
(100 MHz, DMSO-d6): δ 14.8, 16.8, 36.6, 38.2, 61.0, 107.3, 125.9, 127.4, 128.2, 128.8, 130.0, 
137.7, 141.9 144.8, 146.8, 166.7, 168.0; ESI-MS calcd. m/z 414.1 found 415.1 [M + H]
+
; Anal. 
Calcd. for C21H19ClN2O5: C, 60.82; H, 4.64; N, 6.75. found: C, 60.82; H, 4.64; N, 6.71 %. 
Ethyl-1-(4'-chlorophenyl)-2-methyl-6-oxo-4-(3'',4'',5''-trimethoxyphenyl)-1,4,5,6 
tetrahydropyridine-3-carboxylate (5g)  
Pale yellow solid; Yield 95 %; m.p. 135–136 °C. IR (ATR νmax): 3040, 2105, 1750, 1614, 1410, 
1315, 1235 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.28 (t, J = 7.2 Hz, 3H, −CH3s, 
3H, −CH3), 2.32 (dd, J = 7.2, 5.2 Hz, 1H, −CH23.01 (dd, J = 7.2, 5.2 Hz, 1H, −CH2s, 
3H, −OCH3), s, 6H, −OCH3), 3.88 (dd, J = 7.2, 5.2 Hz, 1H, −CH), 4.16 (q, J = 7.2 Hz, 2H, 
−CH2), 7.00−7.63 (m, 6H, Ar-H); 
13
C NMR (100 MHz, DMSO-d6): δ 13.5, 16.5, 27.5, 37.6, 
55.6, 56.5, 60.7, 95.3,106.1, 106.8, 128.1, 129.5, 131.8, 137.6, 144.8, 159.5, 160.0, 166.1, 167.6; 
ESI-MS calcd. m/z 459.1 found 460.1 [M + H]
+
; Anal. Calcd. for C24H26ClNO6: C, 62.68; H, 
5.70; N, 3.05. found: C, 62.70; H, 5.73; N, 3.10 %. 
Ethyl-2-methyl-1-(4'-nitrophenyl)-6-oxo-4-(3'',4'',5''-trimethoxyphenyl)-1,4,5,6-
tetrahydropyridine-3-carboxylate (5h)  
Pale yellow solid; Yield 85 %; m.p. 130–131 °C. IR (ATR νmax): 3015, 2120, 1740, 1628, 1550, 
1355, 1210 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.30 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.29 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.00 (dd, J = 6.8, 4.8 Hz, 1H, −CH2s, 
3H, −OCH3), s, 6H, −OCH3), 3.84 (dd, J = 6.8, 4.8 Hz, 1H, −CH), 4.07 (q, J = 6.8 Hz, 2H, 
−CH2), 7.03−7.68 (m, 6H, Ar-H); 
13
C NMR (100 MHz, DMSO-d6): δ 15.2, 17.7, 28.8, 56.7, 
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57.9, 62.2, 92.2, 107.7, 108.2, 126.3, 127.0, 141.7, 144.7, 146.4, 161.1, 161.6, 167.5, 169.5; ESI-
MS calcd. m/z 470.1 found 471.1 [M + H]
+
; Anal. Calcd. for C24H26N2O8: C, 61.27; H, 5.57; N, 
5.95. found: C, 61.29; H, 5.59; N, 5.99 %. 
Ethyl-1-(4'-chlorophenyl)-4-(4''-hydroxyphenyl)-2-methyl-6-oxo-1,4,5,6 
tetrahydropyridine-3-carboxylate (5i)  
Yellow solid; Yield 90 %; m.p. 155–156 °C. IR (ATR νmax): 3105, 2919, 2110, 1745, 1624, 
1550, 1225 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.42 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.27 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.08 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.79 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.07 (q, J = 6.8 Hz, 2H, −CH2), s, 1H, −OH), 7.12−7.56 (m, 8H, 
Ar-H); 
13
C NMR (100 MHz, DMSO-d6): δ 13.1, 16.1, 37.6, 38.5, 60.5, 107.7, 114.5, 127.5, 
128.9, 130.6, 133.4, 135.7, 137.2, 144.5, 156.2, 166.6, 168.5; ESI-MS calcd. m/z 385.1 found 
386.1 [M + H]
+
; Anal. Calcd. for C21H20ClNO4: C, 65.37; H, 5.22; N, 3.63. found: C, 65.34; H, 
5.27; N, 3.66 %. 
Ethyl-4-(4'-hydroxyphenyl)-2-methyl-1-(4''-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-
carboxylate (5j)  
Yellow solid; Yield 85 %; m.p. 179–180 °C. IR (ATR νmax): 3210, 2925, 2105, 1745, 1625, 
1573, 1230 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.29 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.28 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.03 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.84 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.06 (q, J = 6.8 Hz, 2H, −CH2), s, 1H, −OH), 6.91−7.96 (m, 8H, 
Ar-H); 
13
C NMR (100 MHz, DMSO-d6): δ 13.1, 15.5, 36.3, 38.1, 59.2, 107.4, 114.0, 123.8, 
126.1, 127.7, 132.7, 138.4, 142.0, 144.3, 155.2, 165.8, 168.1; ESI-MS calcd. m/z 396.1 found 
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397.1 [M + H]
+
; Anal. Calcd. for C21H20N2O6: C, 63.63; H, 5.09; N, 7.07. found: C, 63.60; H, 
5.05; N, 7.08 %. 
Ethyl-4-(4-hydroxyphenyl)-2-methyl-6-oxo-1-p-tolyl-1,4,5,6-tetrahydropyridine-3-
carboxylate (5k)  
Yellow solid; Yield 90 %; m.p. 181–182 °C. IR (ATR νmax): 3220, 2907, 2105, 1745, 1610, 
1553, 1235 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.30 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.24 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.01 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.87 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.14 (q, J = 6.8 Hz, 2H, −CH2), s, 1H, −OH), 6.99−7.72 (m, 8H, 
Ar-H); 
13
C NMR (100 MHz, DMSO-d6) δ 13.2, 16.4, 25.7, 30.0, 38.1, 60.6, 106.7, 113.7, 
123.6, 126.6, 128.4, 134.0, 133.4, 142.8, 145.6, 155.6, 166.4, 168.6; ESI-MS calcd. m/z 365.1 
found 366.1 [M + H]
+
; Anal. Calcd. for C21H20N2O6: C, 72.31; H, 6.34; N, 3.83. found: C, 72.56; 
H, 6.40; N, 3.64 %. 
 Ethyl-4-(4'-hydroxyphenyl)-1-(4''-methoxyphenyl)-2-methyl-6-oxo-1,4,5,6-
tetrahydropyridine-3-carboxylate (5l)  
Yellow solid; Yield 92 %; m.p. 168–169 °C. IR (ATR νmax): 3230, 2910, 2107, 1752, 1616, 
1550, 1325 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.36 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.24 (dd, J = 6.8, 4.8 Hz, 1H, −CH22.96 (dd, J = 6.8, 4.8 Hz, 1H, −CH2s, 
3H, −OCH3), 3.89 (dd, J = 6.8, 4.8 Hz, 1H, −CH), 4.09 (q, J = 6.8 Hz, 2H, −CH2), s, 1H, 
−OH), 6.82−7.27 (m, 8H, Ar-H); 13C NMR (100 MHz, DMSO-d6): δ 12.6, 15.8, 36.5, 37.5, 
54.7, 60.1, 107.7, 116.8, 123.3, 127.4, 141.1, 142.7, 144.4, 145.6, 149.4, 166.6, 168.7; ESI-MS 
calcd. m/z 381.1 found 382.1 [M + H]
+
; Anal. Calcd. for C21H20N2O6: C, 69.28; H, 6.08; N, 3.67. 
found: C, 69.15; H, 6.34; N, 3.60 %. 
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Ethyl-1-(4'-methoxyphenyl)-2-methyl-4-(4''-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-
3-carboxylate (5m)  
Yellow solid; Yield 90 %; m.p. 176–177 °C. IR (ATR νmax): 2963, 2129, 1755, 1615, 1562, 
1303, 1208 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.41 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.25 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.11 (dd, J = 6.8, 4.8 Hz, 1H, −CH2s, 
3H, −OCH3), 3.80 (dd, J = 6.8, 4.8 Hz, 1H, −CH), 4.14 (q, J = 6.8 Hz, 2H, −CH2), 7.26−8.11 (m, 
8H, Ar-H); 
13
C NMR (100 MHz, DMSO-d6) δ 13.5, 16.6, 36.5, 37.7, 55.8, 60.1, 107.3, 116.4, 
123.8, 126.4, 128.1, 133.1, 138.8, 144.1, 150.9, 160.0, 165.8, 167.7; ESI-MS calcd. m/z 410.1 
found 411.1 [M + H]
+
; Anal. Calcd. for C21H20N2O6: C, 64.38; H, 5.40; N, 6.83. found: C, 64.20; 
H, 5.55; N, 6.96 %. 
Ethyl-1-(4'-chlorophenyl)-2-methyl-4-(4''-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-
carboxylate (5n)  
Yellow solid; Yield 90 %; m.p. 133–134 °C. IR (ATR νmax): 3007, 2130, 1735, 1628, 1550, 
1360, 1212 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ 1.26 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.23 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.02 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.84 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.14 (q, J = 6.8 Hz, 2H, −CH2), 7.29−8.11 (m, 8H, Ar-H); 
13
C NMR 
(100 MHz, DMSO-d6): δ = 14.1, 16.5, 37.6, 60.7, 107.8, 123.7, 124.3, 126.5, 128.2, 133.4, 
136.5, 142.5, 144.6, 149.6, 166.4, 168.4; ESI-MS calcd. m/z 414.1 found 415.7 [M + H]
+
; Anal. 
Calcd. for C21H19ClN2O5: C, 60.80; H, 4.62; N, 6.75. found: C, 60.84; H, 4.61; N, 6.73 %. 
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Ethyl-2-methyl-1,4-bis-(4'-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate 
(5o)  
Dark yellow solid; Yield 90 %; m.p.: 141–142 °C. IR (ATR νmax): 3017, 2112, 1745, 1625, 1553, 
1340, 1215 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ1.29 (t, J = 6.8 Hz, 3H, −CH3s, 
3H, −CH3), 2.23 (dd, J = 6.8, 4.8 Hz, 1H, −CH23.11 (dd, J = 6.8, 4.8 Hz, 1H, −CH2), 3.81 (dd, 
J = 6.8, 4.8 Hz, 1H, −CH), 4.10 (q, J = 6.8 Hz, 2H, −CH2), 7.64−8.08 (m, 8H, Ar-H); 
13
C NMR 
(100 MHz, DMSO-d6) δ = 13.6, 16.4, 35.3, 36.8, 38.4, 60.1, 107.7, 123.1, 124.2, 126.1, 141.1, 
142.4, 144.3, 145.6, 149.8, 166.2, 168.7; ESI-MS calcd. m/z 425.1 found 426.1 [M + H]
+
; Anal. 
Calcd. for C21H19N3O7: C, 59.29; H, 4.50; N, 9.88. found: C, 59.26; H, 4.54; N, 9.90 %. 
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Table 1  Optimization of the catalyst for the synthesis of 5g
a
 
Entry Catalyst  
Reaction condition 
25 ºC  80 ºC  MW  US  
Time 
(min) 
Yield 
(%) 
b
 
Time 
(min) 
Yield 
(%) 
b
 
Time 
(min) 
Yield 
(%) 
b
 
Time 
(min) 
Yield 
(%) 
b
 
1  No catalyst  720 15  720 30  20  40  15 55  
2  InCl3 720 14  720 35  20  45  15 55  
3  K2CO3 720 15  720 30  20  50  15 60  
4  Et3N 720 10  720 35  20  50  15 65  
5  Amberlite
c 
720 15  720 30  20  45  15 60  
6  PPh3 720 10  720 30  20  55  15 60  
7  L-Proline 720 13  720 25  20  50  15 55  
8  Piperidine 720 14  720 20  20  50  15 65  
9  SiO2
c 
720 10  720 30  20  50  15 55 
10  SiO2–I
c 
720 20  720 40  20  65  15 95  
aReaction conditions: Meldrum’s acid (1 mmol), 3,4,5-trimethoxybenzaldehyde (1 mmol), 4-
chloroaniline (1 mmol), ethyl acetoacetate (1 mmol), catalyst (0.1 mmol); MW: microwaves; US: 
ultrasound; 
b
Isolated yields;  
c
0.1 g. 
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Table 2  Optimization of the solvent for the synthesis of 5g
a
 
Entry Solvent 
Reaction condition 
25 ºC 80 ºC MW US 
Time 
(min
) 
Yield 
(%) 
b
 
Time 
(min) 
Yield 
(%) 
b
 
Time 
(min
) 
Yield 
(%) 
b
 
Time 
(min
) 
Yield 
(%) 
b
 
1 H2O 720  15 720  20 20 25 15 45 
2 CHCl3 720  16 720  25 20 35 15 45 
3 n-Hexane 720  15 720  25 20 40 15 50 
4 CH3CN 720  18 720  30 20 45 15 55 
5 AcOH 720  12 720  35 20 40 15 50 
6 DMSO 720 12 720 25 20 30 15 58 
7 THF 720  10 720  20 20 35 15 60 
8 Xylene 720  05 720  15 20 30 15 55 
9 Ethanol 720  10 720  20 20 30 15 75 
10 No solvent 720 25 720 30 20 40 15 95 
aReaction conditions: Meldrum’s acid (1 mmol), 3,4,5-trimethoxybenzaldehyde (1 mmol), 4-
chloroaniline (1 mmol), ethyl acetoacetate (1 mmol), catalyst (0.1 g); MW: microwaves; US: 
ultrasound; 
b
Isolated yields. 
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Table 3  Optimization of the amount of SiO2–I for the synthesis of 5g
a
 
Entry 
Amount of  SiO2–
I (g) 
Time 
(min) 
Yield 
(%) 
b
 
1 0.05 15 60 
2 0.06 15 65 
3 0.07 15 70 
4 0.10 15 95
 
5 0.15 15 95 
6 0.20 15 90 
7 0.25 15 85 
a
Reaction conditions: Meldrum’s acid (1 mmol), 3,4,5-trimethoxybenzaldehyde (1 mmol), 4-
chloroaniline (1 mmol), ethyl acetoacetate (1 mmol); 
b
Isolated yields 
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Table 4  Synthesis of 1,4,5,6-tetrahydropyridine-3-carboxylate derivatives 
Entry R X Product Yield (%) 
a
 m.p.(ºC) 
1 H H 5a 87 140–141 
2 H 4-Cl 5b 87 155–156 
3 4-Cl H 5c 87 160–161 
4 4-Cl 4-Cl 5d 90 176–177 
5 4-Br 4-Cl 5e 90 156–157 
6 4-Cl 4-NO2 5f 85 177–178 
7 3,4,5-(OCH3)3 4-Cl 5g 95 135–136 
8 3,4,5-(OCH3)3 4-NO2 5h 85 130–131 
9 4-OH 4-Cl 5i 90 155–156 
10 4-OH 4-NO2 5j 85 179–180 
11 4-OH 4-CH3 5k 90 181–182 
12 4-OH 4-OCH3 5l 92 168–169 
13 4-NO2 4-OCH3 5m 90 176–177 
14 4-NO2 4-Cl 5n 90 133–134 
15 4-NO2 4-NO2 5o 90 141–142 
a
Isolated yields. 
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Figure 1  Reusability of SiO2–I in the synthesis of 5g 
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Scheme 1. Synthesis of 1,4,5,6-tetrahydropyridine-3-carboxylate derivatives 
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Scheme 2  A plausible mechanism for the formation of compounds 5 
 
